Ferrous Gluconate

Ferrous gluconate is elemental iron bound to gluconic acid — a well-absorbed organic iron salt that supplies iron in the reduced ferrous (Fe²⁺) state the gut takes up most readily. At only ~12% elemental iron by weight it is the least iron-dense of the common ferrous salts (versus ~20% for sulfate and ~33% for fumarate), so more compound is needed per dose — but it is frequently chosen because it tends to be gentler on the gut than ferrous sulfate. For iron’s full, form-agnostic evidence base — who benefits, effect sizes, pregnancy, safety — see the Iron hub. Only what is specific to the gluconate form is covered here.

Ferrous gluconate is elemental iron bound to gluconic acid — a well-absorbed organic iron salt that supplies iron in the reduced ferrous (Fe²⁺) state the gut takes up most readily. At only ~12% elemental iron by weight it is the least iron-dense of the common ferrous salts (versus ~20% for sulfate and ~33% for fumarate), so more compound is needed per dose — but it is frequently chosen because it tends to be gentler on the gut than ferrous sulfate. For iron’s full, form-agnostic evidence base — who benefits, effect sizes, pregnancy, safety — see the Iron hub. Only what is specific to the gluconate form is covered here.

Absorption & Tolerability

Ferrous gluconate is elemental iron bound to gluconic acid — a soluble, well-absorbed organic ferrous salt that supplies iron in the reduced Fe²⁺ state the duodenal transporter (DMT1) takes up most readily. Once dissolved, iron from gluconate is absorbed much like iron from the other common ferrous salts: there is no meaningful bioavailability advantage per milligram of elemental iron.

Its defining trade-off is density versus tablet count, not absorption. At only ~12% elemental iron by weight — 11.6% for the dihydrate, 12.5% anhydrous — it is the least iron-dense of the common ferrous salts, against about 20% for ferrous sulfate and 33% for ferrous fumarate. A typical 325 mg ferrous gluconate tablet therefore supplies only about 35–38 mg elemental iron, so reaching a given elemental target takes more compound, and often more tablets, than with sulfate or fumarate.

The tolerability claim, honestly stated. Gluconate is widely marketed as “gentler on the gut” than ferrous sulfate, and small comparative trials support that: in a peritoneal-dialysis study, high-dose gluconate was both better absorbed and better tolerated than sulfate ^{3Reference 3Lausević M et al. · 2006Clinical trialResorption and tolerance of high doses of ferrous sulfate and ferrous gluconate in patients on peritoneal dialysis — comparative clinical trialView study →}, and in a small pregnancy trial liquid ferrous gluconate produced no side-effects or drop-outs, versus one drop-out each for solid sulfate and gluconate ^{4Reference 4Casparis D et al. · 1996RCTEffectiveness and tolerability of oral liquid ferrous gluconate in iron-deficiency anaemia in pregnancy and the immediate post-partum period — randomised comparative trialView study →}.

But the best-powered evidence is more sobering. A systematic review of 111 studies (10,695 patients) put ferrous gluconate’s overall adverse-event rate at 30.9% (GI 29.9%) — only marginally below plain ferrous sulfate at 32.3% (GI 30.2%), and far above extended-release sulfate-with-mucoproteose at 4.1% ^{1Reference 1Cancelo-Hidalgo MJ et al. · 2013Systematic reviewTolerability of different oral iron supplements: a systematic reviewView study →}. Separately, a meta-analysis of 43 RCTs found ferrous sulfate roughly doubles GI side-effects versus placebo (OR 2.32) with no dose–response relationship, implying the discomfort is intrinsic to delivering absorbable ferrous iron to the gut rather than a property of one salt ^{2Reference 2Tolkien Z et al. · 2015Meta-analysisFerrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysisView study →}.

The practical reading: gluconate’s GI edge over sulfate is real but modest, and much of its “gentler” reputation reflects the lower elemental dose per tablet rather than the gluconate ion itself.

The label rules that actually matter are form-agnostic: read the elemental iron figure, not the salt weight; take it with a source of vitamin C to modestly boost non-heme absorption; and keep it apart from tea, coffee, calcium and antacids, which blunt non-heme iron uptake.

What the Evidence Says

Gluconate-specific outcome data are thin — and that is expected. Most large iron-efficacy trials used ferrous sulfate, so there is little reason to expect gluconate to differ on clinical outcomes once matched for elemental dose. Where gluconate has been tested head-to-head it performs as a legitimate repletion salt: in iron-deficiency anaemia of pregnancy, liquid ferrous gluconate produced significant rises in haemoglobin (+2.83 g/dL, about 32%), haematocrit and serum iron over 30 days, with efficacy statistically indistinguishable from sulfate, fumarate-class and ferric-succinylate comparators — while delivering a lower cumulative iron dose and the fewest side-effects in that small trial ^{4Reference 4Casparis D et al. · 1996RCTEffectiveness and tolerability of oral liquid ferrous gluconate in iron-deficiency anaemia in pregnancy and the immediate post-partum period — randomised comparative trialView study →}. In dialysis patients, high-dose gluconate matched or slightly exceeded sulfate on serum-iron response ^{3Reference 3Lausević M et al. · 2006Clinical trialResorption and tolerance of high doses of ferrous sulfate and ferrous gluconate in patients on peritoneal dialysis — comparative clinical trialView study →}.

For iron’s full, form-agnostic evidence base — efficacy across every application, effect sizes, the deficiency-versus-repletion distinction, pregnancy, and the scored evidence table — defer to the Iron hub. This page does not re-score iron’s applications.

One dosing insight applies to gluconate and is worth flagging here, because it changes how any ferrous salt should be taken. Stable-isotope RCTs showed that a single oral dose of 60 mg or more raises hepcidin for roughly 24 hours, blunting absorption of a second same-day or next-day dose; giving iron on alternate days as a single morning dose increased cumulative fractional absorption (21.8% against 16.3%) ^{5,6Reference 5Stoffel NU et al. · 2017RCTIron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women — randomised controlled trialsView study →Reference 6Stoffel NU et al. · 2020ReviewOral iron supplementation in iron-deficient women: how much and how often? — reviewView study →}. A later double-blind RCT (n=150) confirmed that, at equal total dose, alternate-day dosing did not lower ferritin but produced fewer GI side-effects and less iron deficiency at 6 months ^{7Reference 7von Siebenthal HK et al. · 2023RCTAlternate day versus consecutive day oral iron supplementation in iron-depleted women: a randomized double-blind placebo-controlled studyView study →}.

So for a low-elemental salt like gluconate, the modern approach — fewer, larger, alternate-day morning doses with vitamin C — matters more than the choice of salt.

Dosage

These are doses studied in research, not a personal recommendation. Supplement iron only for a diagnosed need, under clinician guidance.

Iron is dosed as elemental iron, never the weight of the gluconate salt — the single most important labelling point for this form. Because ferrous gluconate is only about 12% elemental iron, a 325 mg tablet delivers only 35–38 mg of elemental iron, so more milligrams of salt are needed for a given elemental target than with sulfate (~20%) or fumarate (~33%).

• Dietary reference (form-agnostic, from the Iron hub): RDA 8 mg/day for adult men and post-menopausal women, 18 mg/day for menstruating women, 27 mg/day in pregnancy — all elemental iron.
• Tolerable Upper Intake Level: 45 mg/day elemental iron for adults, set on GI distress and counting supplemental iron. Therapeutic repletion doses legitimately exceed the UL under clinician guidance for a diagnosed deficiency.
• Therapeutic repletion: clinician-directed for a diagnosed deficiency, higher than the dietary reference.
• How to take it: with vitamin C to modestly increase non-heme absorption ^{8Reference 8Skolmowska D · 2022Effectiveness of dietary intervention with iron and vitamin C administered separately in improving iron status in young women — intervention studyView study →}; separated from calcium, antacids, acid-suppressing drugs, tea and coffee; and — per the isotope and RCT data above — increasingly as a single morning dose on alternate days rather than divided daily doses, which improves fractional absorption and reduces GI side-effects at equal total dose ^{5,6,7Reference 5Stoffel NU et al. · 2017RCTIron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women — randomised controlled trialsView study →Reference 6Stoffel NU et al. · 2020ReviewOral iron supplementation in iron-deficient women: how much and how often? — reviewView study →Reference 7von Siebenthal HK et al. · 2023RCTAlternate day versus consecutive day oral iron supplementation in iron-depleted women: a randomized double-blind placebo-controlled studyView study →}.

Safety

The safety profile is iron’s, not the gluconate ion’s — gluconic acid is a benign dietary acid. General iron cautions live on the Iron hub; the points specific to this form:

• Gastrointestinal upset is the dose-limiting effect. Nausea, epigastric discomfort, constipation and dark stools are the common, dose-related effects of all oral ferrous salts. Gluconate is often somewhat gentler than plain sulfate, but the advantage is modest — about 31% against 32% adverse events in the largest review ^{1Reference 1Cancelo-Hidalgo MJ et al. · 2013Systematic reviewTolerability of different oral iron supplements: a systematic reviewView study →} — and GI effects do not scale cleanly with dose across salts ^{2Reference 2Tolkien Z et al. · 2015Meta-analysisFerrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysisView study →}. The first levers for tolerability are lowering the elemental dose, taking it with food, and alternate-day dosing ^{7Reference 7von Siebenthal HK et al. · 2023RCTAlternate day versus consecutive day oral iron supplementation in iron-depleted women: a randomized double-blind placebo-controlled studyView study →}.
• Acute overdose is the serious hazard. Iron overdose is dangerous and a leading cause of fatal poisoning in young children, with potential for corrosive gut injury and multi-organ toxicity. Keep away from children. This hazard is identical for every ferrous salt.
• Drug interactions. Iron salts chelate several drugs in the gut. Separate iron from tetracycline and fluoroquinolone antibiotics, levothyroxine, and bisphosphonates by several hours; calcium supplements, antacids and acid-suppressing drugs (PPIs, H2 blockers) also reduce iron absorption.

Pregnancy and lactation: iron requirements rise in pregnancy (RDA 27 mg/day elemental), and oral iron is standard therapy for diagnosed or at-risk deficiency. Ferrous gluconate has been used specifically in pregnancy-associated iron-deficiency anaemia with good efficacy and tolerability in a small trial ^{4Reference 4Casparis D et al. · 1996RCTEffectiveness and tolerability of oral liquid ferrous gluconate in iron-deficiency anaemia in pregnancy and the immediate post-partum period — randomised comparative trialView study →}. Supplementation should follow assessment of iron status rather than being assumed universally beneficial, and dose and form choices belong with the clinician.

Scope disclosure. Interactions were assessed: chelation with tetracyclines, fluoroquinolones, levothyroxine and bisphosphonates, and reduced absorption with calcium, antacids and acid suppressants — all iron-class effects rather than gluconate-specific ones. Pregnancy and lactation were assessed, with the deeper base on the hub. An Upper Limit does exist and is form-agnostic: 45 mg/day elemental iron for adults.

Related compounds / cross-links

• Hub: Iron — the full, form-agnostic evidence base, intake references, and safety.
• Sibling forms: Ferrous sulfate (~20% elemental, the reference salt), Ferrous fumarate (~33% elemental, most iron per tablet), Ferrous bisglycinate (amino-acid chelate, gentlest, premium).
• Carrier: Gluconic acid — the benign dietary acid this salt is built on.
• Enhancer: Vitamin C — modestly increases single-meal non-heme absorption.

References

1. Cancelo-Hidalgo MJ, Castelo-Branco C, Palacios S, et al. (2013). Tolerability of different oral iron supplements: a systematic review. Current Medical Research and Opinion. https://pubmed.ncbi.nlm.nih.gov/23252877/
2. Tolkien Z, Stecher L, Mander AP, Pereira DI, Powell JJ (2015). Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS One. https://pubmed.ncbi.nlm.nih.gov/25700159/
3. Lausević M, Jovanović N, Ignjatović S, et al. (2006). Resorption and tolerance of high doses of ferrous sulfate and ferrous gluconate in patients on peritoneal dialysis — comparative clinical trial. Vojnosanitetski Pregled. https://pubmed.ncbi.nlm.nih.gov/16502988/
4. Casparis D, Del Carlo P, Branconi F, et al. (1996). Effectiveness and tolerability of oral liquid ferrous gluconate in iron-deficiency anaemia in pregnancy and the immediate post-partum period — randomised comparative trial. Minerva Ginecologica. https://pubmed.ncbi.nlm.nih.gov/9005381/
5. Stoffel NU, Cercamondi CI, Brittenham G, et al. (2017). Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women — randomised controlled trials. The Lancet Haematology. https://pubmed.ncbi.nlm.nih.gov/29032957/
6. Stoffel NU, von Siebenthal HK, Moretti D, Zimmermann MB (2020). Oral iron supplementation in iron-deficient women: how much and how often? — review. Molecular Aspects of Medicine. https://pubmed.ncbi.nlm.nih.gov/32650997/
7. von Siebenthal HK, Gessler S, Vallelian F, et al. (2023). Alternate day versus consecutive day oral iron supplementation in iron-depleted women: a randomized double-blind placebo-controlled study. EClinicalMedicine. https://pubmed.ncbi.nlm.nih.gov/38021373/
8. Skolmowska D, Głąbska D (2022). Effectiveness of dietary intervention with iron and vitamin C administered separately in improving iron status in young women — intervention study. International Journal of Environmental Research and Public Health. https://pubmed.ncbi.nlm.nih.gov/36231177/

View all 8 references▾

Last checked: August 2026.